Description
A rich, nourishing cream that provides up to 45 uses while leveraging a unique postbiotic ingredient to promote a healthy microbiome ideal for skin restoration. Clinically proven to restore the skin in 48 hours*. A dermatologist recommended multi-purpose skin barrier solution. Safe for infants, children and adults. Accepted by the National Eczema Association.
- Multi-purpose skin barrier cream with up to 45 uses. Ideal to use as a daily moisturizer or to soothe sensitive skin prone to visible redness or dryness, minor cuts & scrapes, perioral area, cracked or chapped skin, diaper area, after sun exposure and more.
- Helps restore and promote an optimal environment for skin recovery.
- Helps maintain proper hydration levels for skin restoration.
- Safe and gentle for infants, children, and adults, Cicalfate+ is the perfect choice for the whole family.
- Formulated to minimize risk of allergic reactions.
- Fragrance-free, paraben-free, sulfate-free, alcohol-free, silicone-free, non-comedogenic.
- Accepted by the National Eczema Association.
Clinical Results:
- Restores the skin in 48hrs (1)
- Helps restore skin for visible improvement in 2 days (2)
- -80% reduction in skin discomfort after 48 hours (3)
- Clinically proven to soothe, hydrate and restore a damaged skin barrier for those undergoing cancer treatments (4)
(1)Promotes epidermal restoration from 48h. Clinical study under dermatological, pediatric and gynecological control, 248 subjects, 2 applications per day for 21 days, clinical rating at 48 hours.
(2)Comparative study on 20 subjects (18-45 years old) following de-epidermization by Erbium YAG Laser on front surface of forearms. Application of Cicalfate+ for 21 days. 1 semi-occlusive application per day from D1 to D6. 2 open applications per day from D7 to D21. p<0.0001 vs untreated skin.
(3)Self-scoring under dermatological, pediatric, gynecological control on 88 subjects, 2 applications per day for 22 days.
(4) A, Gautier D. Evaluation of Efficacy and Tolerability of a Repairing Protective Cream Containing the Postbiotic Aquaphilus Dolomiae Extract G2 for Onco-Dermatological Indications. Poster presented at EADO Congress, April 2024.